The Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke’s Medical Center assembles a renowned group of experts specializing in neurosurgery, medical oncology, radiation oncology, neuropathology, and neuroradiology. This multidisciplinary team collaborates to create individualized treatment plans for patients with brain and spine cancers. Our skilled and compassionate surgeons, physicians, and staff provide the highest quality of care for our patients with the utmost respect for privacy. If you have questions or want to make an appointment, call (832) 957-6500.
Baylor College of Medicine is a participant of the Brain Tumor Trials Collaborative (BTTC), led by the NCI’s Center for Cancer Research.
There’s Every Reason to Choose the Duncan Cancer Center
Every patient seen at the Duncan Cancer Center for brain or spine cancer is seen by our multidisciplinary tumor board. This board is comprised of neurosurgeons, neuro-oncologists, radiation oncologists, neuroradiologists, and neuropathologists to ensure our patients receive a comprehensive treatment plan.
Our neurosurgeons are experts in novel surgical techniques, including Laser Interstitial Thermal Therapy, to treat primary or metastatic brain tumors. Our team is also equipped to do awake craniotomy for the identification of critical brain functions during surgery.
Our physicians are one of only two systems in South Texas using CyberKnife, one of the most advanced radiosurgery systems available.
Benign Tumors We Treat
- Acoustic schwannomas
- Hemangioblastomas
- Meningioma
Malignant Tumors We Treat
- Astrocytoma
- Ependymoma
- Glioblastoma
- Low-grade gliomas
- Medulloblastoma
- Oligodendroglioma
Other Cancers We Treat
- Metastatic brain tumors
- Leptomeningeal disease
- Pituitary Tumors
- Syndromic Cases including neurofibromatosis 1 and 2
- Tuberous sclerosis, including brain lesions
Spine Tumors We Treat
- Metastatic spine cancer
- Primary spine cancer including osteosarcomas and chondrosarcomas
- Spinal cord tumors
About Genetic Testing
We perform extensive genetic testing for our brain tumor patients to discover mutations that may be actionable.
